Breast pain. Mastodynia
Conditions
Interventions
Intervention 1: The case group: Tab vitamin E 400 mg, Daily, for two months, Orally. Intervention 2: Control Group: Diclofenac Gel 1%, amount of 0/25 gr, Twice a day, for two month.
Treatment - Drugs
The case group: Tab vitamin E 400 mg, Daily, for two months, Orally
Control Group: Diclofenac Gel 1%, amount of 0/25 gr, Twice a day, for two month
Sponsors
Islamic Republic Azad of Shahrrood University
Eligibility
Sex/Gender
Female
Age
18 Years to 49 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: having breast pain for more than six month; Patients with substantial pain, its intensity by the physician (visual analog scale) is measured; Other diseases is rejected; infertility is rejected(woman 18_49 age) Exclusion criteria: existence underlying breast disease in examination or sonography if necessary or mammography if necessary; having systemic diseases affecting on breast pains; contrainndication of vitamin E use; contraindication of NSAIDs use includ asthma, Hives, cardiovascular disease, sever renal diease; last tree month of pregnancy and lactation; People who have done open-heart surgery; users of supplementry drugs, NSAID, sedatives, sexual hormonal drugs; addicts and people not trend to be treatment.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: The first day of intervention, 30 days after the intervention, 60 days after the intervention. Method of measurement: Visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Digestive disorder, diarhea, Asthma, Hives, cardiovascular disorder, third month of pregnancy, lactation. Timepoint: The first day of intervention, 30 days after the intervention, 60 days after the intervention. Method of measurement: Questionnair. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Seyed Fatemeh Amirkhalili
Islamic Republic Azad of Ahahrood University
Outcome results
None listed